Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ImmunoCellular Therapeutics’ ICT-107 Recognized As One Of Windhover’s Top 10 Most Licensable Oncology Products
ImmunoCellular Therapeutics’ ICT-107 Recognized As One Of Windhover’s Top 10 Most Licensable Oncology Products
ImmunoCellular Therapeutics’ ICT-107 Recognized As One Of Windhover’s Top 10 Most Licensable Oncology Products
Submitted by
moderatorj
on September 28, 2011 - 8:36pm
Source:
Yahoo/MarketWire
News Tags:
ImmunoCellular
award
oncology
Headline:
ImmunoCellular Therapeutics’ ICT-107 Recognized As One Of Windhover’s Top 10 Most Licensable Oncology Products
Do Not Allow Advertisers to Use My Personal information
